Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Одеський Національний Медичний УніверситетfiledCriticalОдеський Національний Медичний Університет
Priority to UAU201401071UpriorityCriticalpatent/UA91254U/en
Publication of UA91254UpublicationCriticalpatent/UA91254U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Magnetic Treatment Devices
(AREA)
Abstract
A method for treating of diabetic retinopathy provides for affecting the cerebellum with the magnetic field in the plane of its frontal projection transcranially. The magnetic pulses are used with the induction of 0.5-1.0 T at the height of the pulse, 5-15 pulses at the rate of 0.05-0.5 Hz once a day. Furthermore, Deltaran is used intranasally 2-5 times a day at a dose of one ampoule containing 0.3 mg of delta sleep-inducing peptide (as freshly prepared solution). The duration of treatment course is two weeks. If necessary, the course is repeated after 4-6-month interval.
UAU201401071U2014-02-052014-02-05Method for treating of diabetic retinopathy
UA91254U
(en)